SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-037966
Filing Date
2015-05-14
Accepted
2015-05-14 10:04:34
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a15-7965_110q.htm 10-Q 587178
2 EX-31.1 a15-7965_1ex31d1.htm EX-31.1 14323
3 EX-31.2 a15-7965_1ex31d2.htm EX-31.2 14345
4 EX-32.1 a15-7965_1ex32d1.htm EX-32.1 4174
5 EX-32.2 a15-7965_1ex32d2.htm EX-32.2 4578
  Complete submission text file 0001104659-15-037966.txt   4119245

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctrv-20150331.xml EX-101.INS 491493
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20150331.xsd EX-101.SCH 31822
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20150331_cal.xml EX-101.CAL 23902
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20150331_def.xml EX-101.DEF 146490
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20150331_lab.xml EX-101.LAB 297167
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20150331_pre.xml EX-101.PRE 241021
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 15860723
SIC: 2834 Pharmaceutical Preparations